Sci.bio Recruiting

Sci.bio Recruiting Sci.bio Recruiting is a fully integrated recruitment firm featuring RPO & Contract Recruitment, Boutique Executive Search and Contract Staffing Services.

We offer a flexible, value oriented approach and experienced team has a long track record of success

Emerging biotech companies continue to drive hiring across the life sciences industry.At Sci.bio Recruiting, we’re seein...
06/04/2026

Emerging biotech companies continue to drive hiring across the life sciences industry.

At Sci.bio Recruiting, we’re seeing strong demand in areas like:

Cell & Gene Therapy
Oncology
Clinical Operations
Regulatory Affairs
CMC & Manufacturing
AI-Driven Drug Discovery

Some of the most in-demand biotech roles right now include Clinical Trial Managers, Scientists, Clinical Pharmacology, Analytical Development, Clinical Data Management, and Regulatory Affairs professionals.

In this carousel, we break down:
1. Current biotech hiring trends
2. Roles seeing the most demand
3. What emerging biotech companies are looking for in candidates

Which role has been the most difficult to hire for recently? We'd love to hear your perspective below.

Our clients are hiring across the biotech and biopharma landscape. Visit our job board to see the range of roles we’re c...
06/03/2026

Our clients are hiring across the biotech and biopharma landscape. Visit our job board to see the range of roles we’re currently supporting and get a snapshot of the talent needs we’re helping clients address across the industry.

https://loom.ly/WYU_8xg

For hiring managers and talent leaders: What is the most difficult role or skill set for your team to hire for right now?

100% of client respondents rated Sci.bio Recruiting as highly professional, highly accessible, and effective in supporti...
06/02/2026

100% of client respondents rated Sci.bio Recruiting as highly professional, highly accessible, and effective in supporting their hiring efforts.

In an industry where the average staffing satisfaction rate in 2024 was 55%, Sci.bio was rated significantly above the standard performance.

While the numbers matter, what matters more to us is consistency: This is because we show up as a true partner in every search, are accessible throughout the whole process, and deliver support to biotech hiring teams in a competitive market

Connect with us today to learn more about we can provide you and your team support: [email protected]

Sunny days are ahead!While the weather heats up, so does hiring demand across biotech and life sciences. From clinical d...
06/01/2026

Sunny days are ahead!

While the weather heats up, so does hiring demand across biotech and life sciences. From clinical development to regulatory, manufacturing, and beyond, we’re here and ready to support your summer fills with speed, precision, and the right talent connections.

If your team is looking to make moves this season, become a client today: https://loom.ly/eHAnX2w

Another week, another reminder that biotech and biopharma never slow down.This week, the industry saw major momentum aro...
05/29/2026

Another week, another reminder that biotech and biopharma never slow down.

This week, the industry saw major momentum around strategic partnerships, funding, and the continued push toward next-generation therapies.

Pfizer and Innovent Biologics announced a massive $10.5B oncology collaboration focused on antibody-drug conjugates and multispecific antibodies, another sign that global pharma is continuing to invest heavily in oncology innovation and expanding partnerships within China’s growing biotech market. https://loom.ly/cm6FbC4

Meanwhile, Apogee Therapeutics reported promising mid-stage eczema trial data while simultaneously securing up to $1.3B in financing from Blackstone Life Sciences. Investors continue to back companies with strong clinical data and differentiated immunology platforms, even in a selective funding environment. https://loom.ly/t5lIzjY

And on the M&A side, Eli Lilly made headlines with a series of vaccine-focused biotech acquisitions, signaling a broader move to strengthen infectious disease capabilities beyond its core therapeutic areas. The deal activity across biotech continues to show that large pharma is still aggressively searching for innovative platforms and pipelines.
https://loom.ly/11dkoTA

The common theme across all three stories? Capital is still flowing toward differentiated science, strong clinical ex*****on, and scalable platforms.

Excited to see where the industry heads next as we move into June.

In biotech hiring, volume isn’t the advantage, precision is.The reality is that most teams don’t need more resumes. They...
05/27/2026

In biotech hiring, volume isn’t the advantage, precision is.

The reality is that most teams don’t need more resumes. They need the right candidates, surfaced quickly and aligned to both the science and the team.

That’s where specialized recruiting makes a measurable difference.

By narrowing a broad talent pool into a curated shortlist, a focused life sciences recruiting partner helps companies:

- Reduce time spent screening unqualified applicants.
- Improve alignment between role requirements and candidate skill sets.
- Accelerate hiring decisions without sacrificing quality.
- Increase the likelihood of long-term fit and retention.

At Sci.bio Recruiting, this is the standard we operate by, moving beyond volume to deliver highly targeted, scientifically aligned talent.

Because in today’s market, the strongest hires don’t come from the biggest pile; they come from the most intentional process.

Learn More About our Services: [email protected]

The strongest search outcomes don’t come from a fixed approach; they come from iteration.Being open to feedback and will...
05/26/2026

The strongest search outcomes don’t come from a fixed approach; they come from iteration.

Being open to feedback and willing to refine the process along the way is what ensures alignment between clients and candidates stays tight from start to finish. It’s a more dynamic way of working, but it leads to better long-term fits.

If you value a recruiting partner that adjusts with you, not around you, let’s connect: [email protected]

This Memorial Day, we take a moment to honor and remember the brave men and women who made the ultimate sacrifice in ser...
05/25/2026

This Memorial Day, we take a moment to honor and remember the brave men and women who made the ultimate sacrifice in service to our country.

Their dedication and courage have made a lasting impact, and today we reflect with gratitude and respect.

Wishing everyone a meaningful Memorial Day.

05/21/2026

The biotech hiring market is fast-moving, and that creates real opportunity for companies that are ready to act.

Top candidates move quickly for a reason:

- They’re often in multiple interview processes at once
- Many receive outreach from several companies simultaneously
- In-demand profiles can move from first call to offer in just a few weeks
- Delays between stages can shift momentum and attention, elsewhere

What this means for hiring teams is simple: the ability to move efficiently can be the difference between securing top talent and missing out.

The companies seeing the most success today are combining urgency with precision, moving quickly while staying focused on the right fit.

At Sci.bio Recruiting, we help make that possible by delivering curated, high-quality candidate pipelines and enabling faster, more confident hiring decisions.

Because in this market, it’s not just about moving fast, it’s about moving right.

The biotech industry is entering a clear inflection point, driven by two major shifts happening simultaneously: how drug...
05/20/2026

The biotech industry is entering a clear inflection point, driven by two major shifts happening simultaneously: how drugs are discovered and how they are reviewed.

On one side, AI-driven drug discovery continues to attract significant investment, moving the industry further away from traditional “AI-assisted” workflows and toward fully integrated, AI-native development models. The focus is no longer just on accelerating research; it’s on reshaping how pipelines are designed from the start.

On the regulatory side, the FDA is advancing initiatives aimed at modernizing clinical trials through more continuous, real-time data exchange between sponsors and regulators. If adopted at scale, this could meaningfully compress traditional development timelines and change how clinical decision-making is operationalized.

Together, these shifts signal a broader evolution across biotech:

Faster, more adaptive development models
Deeper integration between data, technology, and regulatory strategy
Increased demand for cross-functional talent who can operate in more dynamic development environments

For organizations, this isn’t just a technology shift, it’s an operating model shift.

As these changes move from pilots and capital investment into standard practice, the question becomes less if the industry changes and more about how quickly teams can adapt.

At Sci.bio, we’re seeing increasing demand for talent that can bridge this gap, professionals who understand both the science and the systems behind how modern drug development is evolving.

Read More: https://loom.ly/FzArNkM

Address

150 Grossman Drive
Braintree, MA
02184

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+16175006690

Website

Alerts

Be the first to know and let us send you an email when Sci.bio Recruiting posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sci.bio Recruiting:

Shortcuts

Share

Category